Skip to Main Content

Advertisement

Skip Nav Destination

Welcome to the AAI Journals

The American Association of Immunologists publishes two journals focused on immunology:

  • The Journal of Immunology (The JI) has served immunologists and the research community for more than 100 years by publishing novel, peer-reviewed findings in all areas of experimental immunology.
  • ImmunoHorizons is a fully open-access, peer-reviewed journal committed to advancing the knowledge of immunology.

Don’t miss the opportunity to present and share your latest research. The submission fee for AAI members is free, and we are offering an exciting new opportunity for trainee members. Scan the QR code above and learn what’s new for 2024!

Nearly 60% of AAI member abstract submitters receive travel awards! Join or renew your membership today, and submit your abstract to be eligible for one of the many awards offered. Scan the QR code to learn more!

The Journal of Immunology

The Journal of Immunology (The JI) publishes peer-reviewed manuscripts describing novel findings in all areas of experimental immunology, including both basic and clinical studies.

Impact Factor 5.426

COVID-19, SARS, and MERS Articles

Coronavirus Disease 2019 (COVID-19), Severe Acute Respiratory Syndrome (SARS), and Middle Eastern Respiratory Syndrome (MERS) articles in AAI journals. All articles are free to access.

ImmunoHorizons

ImmunoHorizons is a fully open access, peer-reviewed, online-only journal committed to advancing the knowledge of immunology. All editorial decisions are made by practicing scientists.

AAI Newsletter

The October 2022 issue of the AAI Newsletter is available now online!

Sign Up for New Issue Alerts

Wondering when the next issues of The JI or ImmunoHorizons are coming out?

Sign up for email alerts so that you don't miss an single issue!

 

Join AAI!

Whether you are just entering the field of immunology or have been active in the field for decades, AAI offers membership categories tailored to benefit you at any career stage.

Close Modal

or Create an Account

Close Modal
Close Modal